Published in Clin Immunol Immunopathol on September 01, 1987
Isotype distribution of anticardiolipin antibodies in systemic lupus erythematosus: prospective analysis of a series of 100 patients. Ann Rheum Dis (1990) 1.14
Outcome of pregnancy in patients with autoimmune rheumatic disease before the disease onset. Ann Rheum Dis (1988) 0.94
Epidemiological aspects of Budd-Chiari in Egyptian patients: a single-center study. World J Gastroenterol (2011) 0.92
Isotype profile and clinical relevance of anticardiolipin antibodies in Sjögren's syndrome. Ann Rheum Dis (1992) 0.91
Obstetric and gynaecological profile in patients with primary Sjögren's syndrome. Ann Rheum Dis (1994) 0.86
Antiphospholipid antibodies and HLA associations in primary Sjögren's syndrome. Ann Rheum Dis (1992) 0.83
Anticardiolipin antibodies and occlusive vascular disease of the eye: prospective study. Doc Ophthalmol (1998) 0.81
Antinuclear antibody profiles in relation to specific disease manifestations of systemic lupus erythematosus. Clin Rheumatol (1990) 0.81
Right ventricular diastolic dysfunction in patients with anticardiolipin antibodies and antiphospholipid syndrome. Ann Rheum Dis (2001) 0.81
Antibodies to beta 2-glycoprotein-I: urea resistance, binding specificity, and association with thrombosis. J Clin Immunol (1998) 0.80
Soluble interleukin-2 receptors, antineutrophil cytoplasmic antibodies, and other autoantibodies in patients with ulcerative colitis. Gut (1993) 0.79
Antiphospholipid antibodies: which and when? Postgrad Med J (1990) 0.78
Reassessing the status of antiphospholipid syndrome in systemic lupus erythematosus. Ann Rheum Dis (1992) 0.76
Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis (2002) 20.48
International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop. Arthritis Rheum (1999) 7.67
Preliminary criteria for the classification of Sjögren's syndrome. Results of a prospective concerted action supported by the European Community. Arthritis Rheum (1993) 7.14
Anticardiolipin antibodies: detection by radioimmunoassay and association with thrombosis in systemic lupus erythematosus. Lancet (1983) 6.71
Immune interferon in the circulation of patients with autoimmune disease. N Engl J Med (1979) 5.58
Increased risk of lymphoma in sicca syndrome. Ann Intern Med (1978) 4.63
Rheumatoid arthritis in Greek and British patients. A comparative clinical, radiologic, and serologic study. Arthritis Rheum (1992) 3.92
Sjögren's syndrome (Sicca syndrome): current issues. Ann Intern Med (1980) 3.81
Assessment of the European classification criteria for Sjögren's syndrome in a series of clinically defined cases: results of a prospective multicentre study. The European Study Group on Diagnostic Criteria for Sjögren's Syndrome. Ann Rheum Dis (1996) 3.68
Anticardiolipin antibodies: isotype distribution and phospholipid specificity. Ann Rheum Dis (1987) 3.62
Thrombosis in systemic lupus erythematosus: striking association with the presence of circulating lupus anticoagulant. Br Med J (Clin Res Ed) (1983) 3.53
Anti-phospholipid antibodies. Clin Rheum Dis (1985) 3.43
Pulmonary hypertension in systemic lupus erythematosus. Br Med J (Clin Res Ed) (1983) 3.39
The anticardiolipin syndrome. J Rheumatol (1986) 3.36
Remission of proliferative lupus nephritis following B cell depletion therapy is preceded by down-regulation of the T cell costimulatory molecule CD40 ligand: an open-label trial. Arthritis Rheum (2005) 3.25
Evaluation of the anti-cardiolipin antibody test: report of an international workshop held 4 April 1986. Clin Exp Immunol (1987) 3.02
Malignant lymphoma in primary Sjögren's syndrome: a multicenter, retrospective, clinical study by the European Concerted Action on Sjögren's Syndrome. Arthritis Rheum (1999) 2.99
Defective production of interleukin 1 and interleukin 2 in patients with systemic lupus erythematosus (SLE). J Immunol (1983) 2.95
Disparities in rheumatoid arthritis disease activity according to gross domestic product in 25 countries in the QUEST-RA database. Ann Rheum Dis (2009) 2.61
Evidence for linkage of a candidate chromosome 1 region to human systemic lupus erythematosus. J Clin Invest (1997) 2.57
Cerebral infarction in systemic lupus: association with anticardiolipin antibodies. Clin Exp Rheumatol (1985) 2.51
European multicentre study to define disease activity criteria for systemic sclerosis. II. Identification of disease activity variables and development of preliminary activity indexes. Ann Rheum Dis (2001) 2.49
Thrombosis, recurrent fetal loss, and thrombocytopenia. Predictive value of the anticardiolipin antibody test. Arch Intern Med (1986) 2.35
Thrombocytopenia in SLE and related autoimmune disorders: association with anticardiolipin antibody. Br J Haematol (1985) 2.07
Demonstration of activation of B lymphocytes in New Zealand black mice at birth by an immunoradiometric assay for murine IgM. J Immunol (1977) 2.06
The European Community Study Group on diagnostic criteria for Sjögren's syndrome. Sensitivity and specificity of tests for ocular and oral involvement in Sjögren's syndrome. Ann Rheum Dis (1994) 2.03
Synovitis of recent onset. A clinicopathologic study during the first month of disease. Arthritis Rheum (1973) 2.03
Genetic differences between primary and secondary sicca syndrome. N Engl J Med (1979) 1.93
Affinity purified anti-cardiolipin and anti-DNA antibodies. J Clin Lab Immunol (1985) 1.92
Differences in the clinical manifestations of sicca syndrome in the presence and absence of rheumatoid arthritis. Am J Med (1979) 1.79
Activation of cultured vascular endothelial cells by antiphospholipid antibodies. J Clin Invest (1995) 1.75
Clinical evolution, and morbidity and mortality of primary Sjögren's syndrome. Semin Arthritis Rheum (2000) 1.74
Multiple interferons in the circulation of patients with systemic lupus erythematosus and vasculitis. Arthritis Rheum (1982) 1.73
Effects of infliximab treatment on insulin resistance in patients with rheumatoid arthritis and ankylosing spondylitis. Ann Rheum Dis (2004) 1.73
Patients with anticentromere antibodies, clinical features, diagnoses and evolution. Br J Rheumatol (1993) 1.64
Efficacy and safety of the fully human anti-tumour necrosis factor alpha monoclonal antibody adalimumab (D2E7) in DMARD refractory patients with rheumatoid arthritis: a 12 week, phase II study. Ann Rheum Dis (2003) 1.64
Hypokalaemic paralysis as the presenting manifestation of primary Sjögren's syndrome. Nephrol Dial Transplant (1994) 1.62
Anticardiolipin antibodies: occurrence in Behçet's syndrome. Ann Rheum Dis (1984) 1.61
Crossreactivity of antiphospholipid antibodies. J Clin Lab Immunol (1985) 1.60
High prevalence of anti-cardiolipin and other autoantibodies in a healthy elderly population. Clin Exp Immunol (1987) 1.59
Anticardiolipin antibodies in autoimmune thrombocytopenic purpura. Br J Haematol (1985) 1.56
Radiographic evidence of disease progression in methotrexate treated and nonmethotrexate disease modifying antirheumatic drug treated rheumatoid arthritis patients: a meta-analysis. J Rheumatol (1992) 1.56
Anti-Ro(SSA) positive rheumatoid arthritis (RA): a clinicoserological group of patients with high incidence of D-penicillamine side effects. Ann Rheum Dis (1985) 1.56
Anti-signal recognition particle autoantibodies: marker of a necrotising myopathy. Ann Rheum Dis (2006) 1.54
Lymphoma development in Sjögren's syndrome: novel p53 mutations. Arthritis Rheum (1999) 1.53
Antibodies to extractable nuclear antigens in 173 patients with DNA-binding positive SLE: an association between antibodies to ribonucleoprotein and Sm antigens observed by counterimmunoelectrophoresis. J Clin Lab Immunol (1982) 1.52
Sjögren's syndrome in patients with the CREST variant of progressive systemic scleroderma. J Rheumatol (1991) 1.51
Remission, relapse, and re-remission of proliferative lupus nephritis treated with cyclophosphamide. Kidney Int (2000) 1.50
Demonstration of circulating immune complexes in Sjögren's syndrome. J Immunol (1979) 1.46
Increased expression of the FoxP3 functional marker of regulatory T cells following B cell depletion with rituximab in patients with lupus nephritis. Clin Immunol (2007) 1.44
Increased prevalence of anti-thyroid antibodies in patients with limited scleroderma. Scand J Rheumatol (2011) 1.41
Induction of high levels of anticardiolipin antibodies in mice by immunization with beta 2-glycoprotein I does not cause fetal death. Am J Obstet Gynecol (1995) 1.41
Induction of psoriatic skin lesions in a patient with rheumatoid arthritis treated with rituximab. Clin Exp Rheumatol (2010) 1.40
Investigation for the presence of anti-erythropoietin antibodies in patients with myelodysplastic syndromes. Eur J Haematol (2001) 1.40
The Th1/Th2 cytokine balance changes with the progress of the immunopathological lesion of Sjogren's syndrome. Clin Exp Immunol (2002) 1.39
Necrotizing vasculitis in Greece: clinical, immunological and immunogenetic aspects. A study of 66 patients. Br J Rheumatol (1997) 1.39
Antiphospholipid syndrome: clinical and therapeutic aspects. Lupus (1994) 1.39
Uterine cervical involvement in a patient with Wegener's granulomatosis. Am J Med (2000) 1.38
Recurrent stroke and multi-infarct dementia in systemic lupus erythematosus: association with antiphospholipid antibodies. Ann Rheum Dis (1987) 1.38
Antiphospholipid antibody syndrome: immunologic and clinical aspects. Semin Arthritis Rheum (1990) 1.37
Respiratory manifestations in primary Sjögren's syndrome. A clinical, functional, and histologic study. Chest (1985) 1.37
Preliminary diagnostic criteria for Sjögren's syndrome. Scand J Rheumatol Suppl (1986) 1.37
Laryngeal involvement in rheumatoid arthritis. Rheumatol Int (2005) 1.36
Clinically significant and biopsy-documented renal involvement in primary Sjögren syndrome. Medicine (Baltimore) (2000) 1.36
Immune mediated mechanism for thrombosis: antiphospholipid antibody binding to platelet membranes. Ann Rheum Dis (1988) 1.35
Immune-mediated skin lesions in patients treated with anti-tumour necrosis factor alpha inhibitors. Scand J Rheumatol (2009) 1.34
Kidney involvement in primary Sjögren's syndrome. Scand J Rheumatol Suppl (1986) 1.33
Radioimmunoassay profile of antiglobulins in connective tissue diseases: elevated level of IgA antiglobulin in systemic sicca syndrome. Clin Exp Immunol (1981) 1.32
Sjögren's syndrome association with HLA-Dw3. N Engl J Med (1977) 1.32
Diffuse fasciitis with eosinophilia. A clinicopathologic study. Am J Med (1980) 1.31
Anticardiolipin antibodies and lupus anticoagulant. Lancet (1984) 1.30
Sjögren's syndrome: a defect in reticuloendothelial system Fc-receptor-specific clearance. Ann Intern Med (1979) 1.29
Sjögren-type syndrome after allogeneic bone-marrow transplantation. Ann Intern Med (1977) 1.27
Central nervous system involvement in Sjogren's syndrome. Ann Rheum Dis (2004) 1.26
HLA-DR expression by labial minor salivary gland tissues in Sjögren's syndrome. Ann Rheum Dis (1986) 1.25
Immunoglobulin A and polymeric IgA rheumatoid factors in systemic sicca syndrome: partial characterization. J Immunol (1982) 1.25
Synergistic effect between IL-10 and bcl-2 genotypes in determining susceptibility to systemic lupus erythematosus. Arthritis Rheum (1998) 1.24
Epidemiology of primary Sjögren's syndrome in north-west Greece, 1982-2003. Rheumatology (Oxford) (2005) 1.23
Mixed monoclonal cryoglobulinemia and monoclonal rheumatoid factor cross-reactive idiotypes as predictive factors for the development of lymphoma in primary Sjögren's syndrome. Arthritis Rheum (1996) 1.23
Ribosomal P autoantibodies in systemic lupus erythematosus. Frequencies in different ethnic groups and clinical and immunogenetic associations. Arthritis Rheum (1996) 1.23
Chorea in systemic lupus erythematosus and "lupus-like" disease: association with antiphospholipid antibodies. Semin Arthritis Rheum (1987) 1.21
Polyclonally triggered B cells in the peripheral blood and bone marrow of normal individuals and in patients with systemic lupus erythematosus and primary Sjögren's syndrome. Arthritis Rheum (1981) 1.21
Occult connective tissue diseases mimicking idiopathic interstitial pneumonias. Eur Respir J (2008) 1.21
Prevalence and outcome of pulmonary fibrosis in microscopic polyangiitis. Eur Respir J (2009) 1.21
Sjögren's syndrome in patients with primary biliary cirrhosis. Hepatology (1990) 1.19
Expression of functional Toll-like receptors by salivary gland epithelial cells: increased mRNA expression in cells derived from patients with primary Sjögren's syndrome. Clin Exp Immunol (2007) 1.17
T cell subpopulations in the labial minor salivary gland histopathologic lesion of Sjögren's syndrome. J Rheumatol (1991) 1.17
Role of cytokines in the pathogenesis of anemia of chronic disease in rheumatoid arthritis. Clin Immunol (1999) 1.17
Anticardiolipin antibodies in Lyme disease. Arthritis Rheum (1988) 1.16
The role of microRNA-146a (miR-146a) and its target IL-1R-associated kinase (IRAK1) in psoriatic arthritis susceptibility. Scand J Immunol (2010) 1.15
Presence of systemic autoimmune disorders in patients with autoimmune thyroid diseases. Ann Rheum Dis (2004) 1.14
Scleroderma, Sjögren-like syndrome, and chronic graft-versus-host disease. Ann Intern Med (1977) 1.14